Cargando…
Bioanalytical Assay Development and Validation for the Pharmacokinetic Study of GMC1, a Novel FKBP52 Co-chaperone Inhibitor for Castration Resistant Prostate Cancer
Background: GMC1 (2-(1H-benzimidazol-2-ylsulfanyl)-N-[(Z)-(4-methoxyphenyl) methylideneamino] acetamide) effectively inhibits androgen receptor function by binding directly to FKBP52. This is a novel mechanism for the treatment of castration resistant prostate cancer (CRPC). Methods: an LC-MS/MS met...
Autores principales: | Ekpenyong, Oscar, Cooper, Candace, Ma, Jing, Guy, Naihsuan C., Payan, Ashley N., Ban, Fuqiang, Cherkasov, Artem, Cox, Marc B., Liang, Dong, Xie, Huan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698315/ https://www.ncbi.nlm.nih.gov/pubmed/33202977 http://dx.doi.org/10.3390/ph13110386 |
Ejemplares similares
-
The FKBP52 Cochaperone Acts in Synergy with β-Catenin to Potentiate Androgen Receptor Signaling
por: Storer Samaniego, Cheryl, et al.
Publicado: (2015) -
Studies of a co-chaperone of the androgen receptor, FKBP52, as candidate for hypospadias
por: Beleza-Meireles, Ana, et al.
Publicado: (2007) -
Analysis of FK506, timcodar (VX-853) and FKBP51 and FKBP52 chaperones in control of glucocorticoid receptor activity and phosphorylation
por: Hinds, Terry D, et al.
Publicado: (2014) -
The GMC superfamily of oxidoreductases revisited: analysis and evolution of fungal GMC oxidoreductases
por: Sützl, Leander, et al.
Publicado: (2019) -
Expansion and evolution of insect GMC oxidoreductases
por: Iida, Kaori, et al.
Publicado: (2007)